Immunochemistry Diagnostic Devices And Equipment Market Outlook 2026–2030 with Major Growth Drivers and Emerging Industry Trends
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Expansion Is Predicted For The Immunochemistry Diagnostic Devices And Equipment Market Between 2026 And 2030?
The immunochemistry diagnostic devices and equipment market size has experienced significant expansion in recent years. This market is forecast to increase from $3.67 billion in 2025 to $4.11 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.9%. The market’s past growth can be attributed to several factors including the rising volumes of clinical diagnostic testing, the increasing prevalence of chronic and infectious diseases, the proliferation of centralized diagnostic laboratories, the expanded application of immunoassays in oncology and endocrinology, and advancements in laboratory infrastructure.
The immunochemistry diagnostic devices and equipment market size is anticipated to undergo rapid expansion in the upcoming years. It is forecast to reach $6.22 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 10.9%. This growth during the projection period stems from an escalating demand for precision diagnostics, the increasing adoption of automated laboratory systems, the broadening of personalized medicine applications, rising investment in advanced diagnostic technologies, and a heightened emphasis on early disease detection. Significant trends expected in the forecast timeframe include the increasing integration of automated immunoassay analyzers, a surging requirement for high-sensitivity diagnostic reagents, the expanding use of multiplex testing platforms, the extension of laboratory automation solutions, and an intensified focus on workflow efficiency and accuracy.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2547&type=smp
What Key Drivers Are Influencing The Growth Of The Immunochemistry Diagnostic Devices And Equipment Market?
The increasing demand for personalized medicine is anticipated to fuel the expansion of the immunochemistry diagnostic devices and equipment market. Personalized medicine involves a medical strategy that tailors healthcare decisions and treatment plans based on an individual’s distinct genetic, genomic, and clinical features, aiming to enhance patient outcomes and reduce negative side effects. The escalating demand for personalized medicine stems from greater awareness and acceptance of customized treatments that factor in individual genetic, lifestyle, and environmental aspects to boost patient results. Personalized medicine requires the creation and application of sophisticated immunochemistry assays to pinpoint specific biomarkers and guide individualized treatment plans for patients. For instance, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization advocating individualized treatment methods, reported that 20 of the 53 new therapeutic molecular entities approved by the Food and Drug Administration in 2023, along with six new gene and cell-based therapies, were categorized as personalized medicines, making up approximately 38 percent of all new molecular entities approved in the country. Consequently, the rising demand for personalized medicine is propelling the growth of the immunochemistry diagnostic devices and equipment market in the future.
Which Market Segments Are Examined In The Immunochemistry Diagnostic Devices And Equipment Market Study?
The immunochemistry diagnostic devices and equipment market covered in this report is segmented –
1) By Product Type: Immunochemistry Analyzers, Immunochemistry Stainers, Incubators, Microscopes, Centrifuges, Autoclaves, Consumables
2) By Consumables: Antibodies, Antigens, Enzymes, Reagents, Stains, Buffers, Disposables, Other Consumables
3) By Application: Endocrinology, Oncology, Cardiology, Therapeutic Drug Development And Monitoring, Infectious Disease Testing, Drugs Of Abuse Testing, Other Applications
4) By End Users: Hospitals And Clinics, Diagnostic Laboratories, Research Labs And Institutes, Biopharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Immunochemistry Analyzers: Chemiluminescence Immunoassay (CLIA) Analyzers, Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Radioimmunoassay (RIA) Analyzers, Fluorescence Immunoassay (FIA) Analyzers
2) By Immunochemistry Stainers: Automated Stainers, Manual Stainers
3) By Incubators: CO2 Incubators, Shaking Incubators, Heated Incubators
4) By Microscopes: Light Microscopes, Fluorescence Microscopes, Electron Microscopes
5) By Centrifuges: Microcentrifuges, Refrigerated Centrifuges, Ultracentrifuges
6) By Autoclaves: Tabletop Autoclaves, Vertical Autoclaves, Horizontal Autoclaves
7) By Consumables: Reagents and Kits, Test Plates, Filters and Membranes, Microplates and Accessories
Which Trends Are Influencing The Immunochemistry Diagnostic Devices And Equipment Market?
Leading companies within the immunochemistry market are actively developing novel products, including multiplex assays, to secure a competitive advantage. Multiplex assays are defined as laboratory techniques that enable the concurrent measurement and analysis of numerous analytes within a single biological sample, providing an efficient and comprehensive approach to investigate multiple factors or biomarkers in a single experiment. For example, in June 2023, Navigate BioPharma Services, Inc., a US-based biotechnology company, launched new multiplex digital PCR assays. These assays were specifically designed for the precise quantification of chimeric antigen receptor (CAR) T cells, an innovative cancer immunotherapy. Built upon the Qiagen QIAcuity digital PCR System, these assays offer the simultaneous measurement of CAR-T cell number, function, and persistence in clinical blood and bone marrow samples without requiring standard curves, capable of detecting CAR-T cells at levels as low as 0.01%. This cutting-edge assay assists clinicians in monitoring responses and safety during clinical trials, thereby facilitating the advancement of CAR-T therapies through its sensitivity, specificity, and efficiency.
Who Are The Primary Competitors In The Immunochemistry Diagnostic Devices And Equipment Market?
Major companies operating in the immunochemistry diagnostic devices and equipment market are Abbott Diagnostics, Roche Diagnostics, Siemens Healthcare Diagnostics, Diamond Diagnostics Inc., Dynex Technologies Inc., Grifols S.A., Hycor Biomedical LLC, Immunodiagnostic Systems, Inova Diagnostics, LabCorp, Mindray Medical International Limited, Ortho Clinical Diagnostics, Quest Diagnostics, Randox Laboratories, Sysmex Corporation, ThermoFisher Scientific Inc., Tosoh Bioscience, Danaher Corporation, Johnson & Johnson, Boditech Med Inc., Beckman Coulter Inc., Bio-Rad Laboratories, bioMérieux Clinical Diagnostics, Carolina Liquid Chemistries Corporate, DiaSorin Inc., Agilent Technologies Inc., Merck KGAA, Eagle Biosciences Inc., Biocare Medical LLC, Elabscience Biotechnology Inc., Bio-Genex Laboratories Inc., Diagnostic Biosystem, Histo-Line Laboratories, Rockland Immunochemicals Inc., Abcam plc, Becton Dickinson & Company, Cell Signaling Technology Inc., ImmunoChemistry Technologies LLC, Genemed Biotechnologies Inc., Miltenyi Biotec GmbH, PerkinElmer Inc., Takara Bio. Inc, Immucor Inc., Quidel Corporation
Read the full immunochemistry diagnostic devices and equipment market report here:
Which Region Is Expected To Register The Fastest Growth In The Immunochemistry Diagnostic Devices And Equipment Market?
North America was the largest region in the global immunochemistry diagnostic devices and equipment market in 2025. Asia-Pacific was the second-largest region in the immunochemistry diagnostic devices and equipment market. The regions covered in the immunochemistry diagnostic devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Immunochemistry Diagnostic Devices And Equipment Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2547&type=smp
Browse Through More Reports Similar to the Global Immunochemistry Diagnostic Devices And Equipment Market 2026, By The Business Research Company
Hematology Diagnostic Devices And Equipment Market Report 2026
Automated Immunoassay Analyzers Market Report 2026
Molecular Diagnostics Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
